1-4 of 4
Jessica L. Teeling
Close
Sort by
Journal Articles

Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

Jessica L. Teeling, Ruth R. French, Mark S. Cragg, Jeroen van den Brakel, Marielle Pluyter, Haichun Huang, Claude Chan, Paul W. H. I. Parren, C. Erik Hack, Michael Dechant, Thomas Valerius, Jan G. J. van de Winkel, Martin J. Glennie
Journal: Blood
Blood (2004) 104 (6): 1793–1800.
https://doi.org/10.1182/blood-2004-01-0039
Published: 2004
Journal Articles

Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect

Wim K. Bleeker, Jessica L. Teeling, C. Erik Hack
Journal: Blood
Blood (2001) 98 (10): 3136–3142.
https://doi.org/10.1182/blood.V98.10.3136
Published: 2001
Journal Articles

Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia

Jessica L. Teeling, Theo Jansen-Hendriks, Taco W. Kuijpers, Masja de Haas, Jan G. J. van de Winkel, C. Erik Hack, Wim K. Bleeker
Journal: Blood
Blood (2001) 98 (4): 1095–1099.
https://doi.org/10.1182/blood.V98.4.1095
Published: 2001
Journal Articles

Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase

Wim K. Bleeker, Jessica L. Teeling, Arthur J. Verhoeven, Gemma M. M. Rigter, Jacques Agterberg, Anton T. J. Tool, Anky H. L. Koenderman, Taco W. Kuijpers, C. Erik Hack
Journal: Blood
Blood (2000) 95 (5): 1856–1861.
https://doi.org/10.1182/blood.V95.5.1856.005k03_1856_1861
Published: 2000